Screens women with suspected endometriosis for fibromyalgia at their first clinic visit
Checks how common fibromyalgia is in women with suspected endometriosis at first visit.
Key facts
- Who runs it
- Assuta Ashdod Hospital
- Where
- Ashdod, IsraelSee the site
- Trial code
- Registry title
- Screening for Fibromyalgia Among Patients With Suspected Endometriosis
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 1 Jul 2024
- Expected to end
- May 2027
- Type of study
- Observational
- Treatments tested
- there is no intervention
- Record updated
- 25 June 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women with suspected endometriosis who come to the endometriosis clinic at Assuta Ashdod Hospital for a first visit.
- Sex
- Women only.
- Disease stage
- Suspected endometriosis at the first clinic visit.
Main reasons for not taking part
- Fibromyalgia already proven before the first visit
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- All women with suspected endometriosis in their first visit to endometriosis clinics in Assuta Ashdod Hospital
Who cannot take part
- Proven fibromyalgia prior to the first visit
Where in Israel
- Assuta Ashdod University HospitalAshdod, IsraelContact: Oshri Barel, MDTaking people
About the trial
What the trial wants to find out
The main purposes of the study are:
Read full original descriptionShow less
To determine the prevalence of fibromyalgia among patients with suspected endometriosis during their initial visit to an endometriosis clinic.
Secondary aims include staging of endometriosis in these patients according to the AAGL (16,17) endometriosis classification and correlate the prevalence of fibromyalgia with ultrasound and surgical findings. Another aim will be to assess the improvement in symptoms in patients diagnosed with both disorders in comparison to patients with either one separately.
All women with suspected endometriosis will be asked to complete the questionnaire before their first visit to the doctor's office.
Study design
* A single center prospective cohort study * All patients attending to Endometriosis clinic at Assuta Ashdod University Hospital with suspected endometriosis at initial visit and who will consent and able to sign the consent form for participation. * Fibromyalgia will be defined by the ACR Preliminary Diagnostic Criteria, including Widespread Pain Index, Symptoms severity scale and somatic symptoms. * The treating physician will blinded to questionnaire results until the end of the visit. * At the end of the visit the questionnaire will be analyzed by one of the investigators and if fibromyalgia is found, the patient will also be referred for treatment of this disorder along with the endometriosis treatment. * Questionnaires will be coded with numbers from 1 to 150.
Treatments tested
- there is no intervention
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Screening for Fibromyalgia Among Patients With Suspected Endometriosis
- Plain-language title
- Screens women with suspected endometriosis for fibromyalgia at their first clinic visitGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 25 June 2025